Susan Hasty, Publisher
Table of Contents . . . July 19th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Gene Therapy Week | Other Publications
Cancer Therapy - Tissue-specific promoters ensure oncolytic viruses target cancer tissues
Clinical Trials - Receptor deficiency stalls the efforts of lung cancer gene therapy
Colon Cancer - The Cre/lox system helps Wnt-targeted gene therapy destroy colorectal cancer
Genetic Engineering - Mutant insulin-like growth factor receptor reduces tumor growth and invasion
Cervical Cancer - FRET inhibition effective for measuring AS-ODN activity in vivo
Collaborations - Immusol initiates collaboration to advance oncology drug-discovery efforts
Colon Cancer - DNA lesion type defines death characteristics of colon carcinoma cells
Drug Development - Atelocollagen leads small interfering RNA to vascular growth factor
Drug Development - Novel lipid-based cochleates drive gene uptake into mammalian cells
Gene Regulation - Ets gene PEA3 assists beta-catenin-Lef-1/c-Jun in OPN transcription regulation
Metastasis - Flt-1 gene transfer suppresses gastric cancer peritoneal metastasis
Neuroscience - EGFR mutations in lung cancer may predict sensitivity to gefitinib therapy
Patents - Two patents awarded for applications of electroporation therapy
Renal Cell Carcinoma - Renal epithelial neoplasms can be associated with familial tumor syndromes
Tumor Suppression - Flavopiridol sensitizes cells to apoptotic stimuli
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.